Amgen
Search results
14 hours ago · Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening...
- 18K
5 days ago · Gilead Sciences is a biopharmaceutical company that develops and markets therapies for HIV, hepatitis, and oncology. Get the latest stock price, earnings, news, and Morningstar ratings for GILD on NASDAQ.
- 1.08
- 0.72
- 2.11
2 days ago · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
- CSL Limited
- Biotechnology
- 32,065
- 94.46B
1 day ago · The biopharmaceutical company earned $6.69 billion during the quarter, compared to the consensus estimate of $6.36 billion. Gilead Sciences had a trailing twelve-month return on equity of 24.34% and a net margin of 1.76%. Gilead Sciences's quarterly revenue was up 5.3% on a year-over-year basis.
- (650) 574-3000
- 333 LAKESIDE DRIVE, FOSTER CITY CA, 94404
- investor_relations@gilead.com
1 day ago · Get the latest information on Gilead Sciences, Inc. (GILD), a biopharmaceutical company that develops and commercializes drugs for various diseases. See stock price, news, financials, statistics, forecast, dividends, profile and chart.
- 78.46B
- 27.45B
- 484.00M
- 1.25B
2 days ago · Mirador Capital Partners LP boosted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.7% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,997 shares of the biopharmaceutical company’s stock after purchasing an additional 853 shares during the period. Mirador Capital Partners […]
5 days ago · Latest Gilead Sciences Inc (GILD:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
